Radius Health (RDUS) Tops Q4 EPS by 19c, Revenues Beat
- Wall Street slides on report of Biden's plan to almost double capital gains tax
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Credit Suisse (CS) Falls 6% on 'Unacceptable Loss' as Exposure to Archegos Grew to More Than $20 Billion, Set to Raise Over $2 Billion to Support Liquidity
- U.S. weekly jobless claims hit 13-month low; home sales tumble
- Cathie Wood's ARK Buys Over 5M Shares of Skillz (SKLZ), Nearly 3M Shares of IPO UiPath (PATH)
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Radius Health (NASDAQ: RDUS) reported Q4 EPS of ($0.23), $0.19 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $62.78 million versus the consensus estimate of $59.44 million.
For earnings history and earnings-related data on Radius Health (RDUS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Radius Health (RDUS) sees growth of 14% for new U.S. TYMLOS patients in Q1
- HCA Holdings (HCA) Tops Q1 EPS by 82c, Revenues Beat; Offers EPS Guidance Above Consensus, Provides FY21 Revenue Outlook
- Old Dominion Freight Line (ODFL) Tops Q1 EPS by 12c, Revenues Beat
Create E-mail Alert Related CategoriesCorporate News, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!